Bioorganic and Medicinal Chemistry Letters p. 1683 - 1686 (1998)
Update date:2022-08-29
Topics:
Lee, Koo
Hwang, Sang Yeul
Yun, Mikyung
Kim, Dong Soo
Novel thrombin inhibitors incorporating thienylamidine at the P1 position were designed and synthesized. These compounds are potent, trypsin- selective and efficacious in the rat model of venous thrombosis. The proposed P1 binding mode in the thrombin active site was confirmed by X-ray crystallographic analysis.
View MoreNanjing Habo Medical Technology Co., Ltd.
Contact:025-85769882
Address:No.108. Ganjiabian east. Qixia District .Nanjing
XI'AN CHUKANG BIOTECHNOLOGY CO.,LTD
Contact:29-63685658 63685359
Address:Room 3-1202,Building 1,Oriental oasis,East of Xianning Road,Xi'an,Shaanxi 710043 P.R.China
Nanyang Tianhua pharmaceutical Co.,Ltd.
Contact:+8618639816203
Address:Longsheng Industrial Park
Changsha Yonta Industry Co., Ltd.
Contact:+ 86-731-8535 2228
Address:Rm.1717, North Bldg., No.368, East 2nd Ring Road(2nd Section)
website:http://www.easchem.com
Contact:+86-731-89722861 89722891
Address:2/F-4/Bld Colorful Palace, No.605 Changsha Ave, Yuhua Area Changsha Hunan China.
Doi:10.1016/j.ica.2021.120495
(2021)Doi:10.3109/14756366.2014.979344
(2015)Doi:10.1134/S0036024413020246
(2013)Doi:10.1021/ja00974a087
(1966)Doi:10.1021/ic700774g
(2007)Doi:10.1021/ja00890a028
(1963)